People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Potenza Therapeutics, Inc. | — | Pharmaceuticals | Series B | $35.0M | $170.0M | 2014 |
Cynthia Seidel-Dugan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cynthia Seidel-Dugan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Luke Evnin | 1 | 12 |
| Arnold Oronsky | 1 | 10 |
| Sakae Asanuma | 1 | 6 |
| David Cordo | 1 | 6 |
| Phil Gutry | 1 | 4 |
| Daniel Hicklin | 1 | 4 |
| Shunichiro Matsumoto | 1 | 1 |
| James Wescott | 1 | 1 |
| Reid Leonard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.